BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for AC Immune SA (ACIU)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for AC Immune SA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:36 pm
Purchase		 2024-09-30 13G AC Immune SA
ACIU		 BIOTECHNOLOGY VALUE FUND L P 19,522,436
19.700%		 4,951,200increase
(+33.98%)		 Filing
2023-12-19
4:53 pm
Purchase		 2023-12-15 13G AC Immune SA
ACIU		 BIOTECHNOLOGY VALUE FUND L P 14,571,236
14.800%		 7,142,857increase
(+96.16%)		 Filing
2023-02-13
5:53 pm
Purchase		 2022-12-31 13G AC Immune SA
ACIU		 BIOTECHNOLOGY VALUE FUND L P 7,428,379
8.900%		 366,000increase
(+5.18%)		 Filing
2022-02-14
1:41 pm
Sale		 2021-12-31 13G AC Immune SA
ACIU		 BIOTECHNOLOGY VALUE FUND L P 7,062,379
9.700%		 -854,279decrease
(-10.79%)		 Filing
2021-01-14
4:48 pm
Sale		 2021-01-12 13G AC Immune SA
ACIU		 BIOTECHNOLOGY VALUE FUND L P 7,916,658
11.000%		 -3,425,847decrease
(-30.20%)		 Filing